This is achieved by inhibiting the high affinity conformation of CD11b/CD18, which consequently hinders the formation of a strong interaction between tumor cells and neutrophils, as demonstrated through dynamic acoustic force measurements. The gene discussed is ITGAM; the disease is neoplasm.